MAP2K1 and cancer: Western blotting results are shown in Figure 6G; silibinin inhibited the expression of TMEM16A in lung adenocarcinoma, thereby inhibited the phosphorylation of MEK1/2 and ERK1/2, and further reduced the expression of cyclin D1 which led to cancer growth retarded.